TATVA vs VALIANTORG: Stock Comparison
TATVA CHIN PHARM CHEM is the larger company by market capitalisation. TATVA CHIN PHARM CHEM shows a higher ROE, a higher dividend yield and faster revenue growth, while VALIANTORG shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
TATVA leads 8; VALIANTORG leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Live Price | ₹1,608.7 | ₹290.95 |
| Day Change | -3.04% | -6.36% |
| Volume | 47,765 | 1 L |
| 52-Week High | ₹1,838.1 | ₹329.5 |
| 52-Week Low | ₹981.5 | ₹195 |
| Distance from 52W High | -12.48% | -11.7% |
Valuation
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Market Cap | ₹3,756 Cr | ₹1,106 Cr |
| P/E Ratio | 73.08x | 19.46x |
| P/B Ratio | 4.8x | 1.39x |
| EPS | ₹4.47 | ₹10.36 |
| Book Value | ₹334.2 | ₹270.87 |
| Dividend Yield | 0.12% | 0% |
Growth
| Metric | TATVA | VALIANTORG |
|---|---|---|
| Revenue Growth (TTM YoY) | 24.4% | 6.9% |
| EPS Growth (TTM YoY) | 907.5% | 269.1% |
| Qtr Sales Growth | -12.18% | 0% |
| Qtr Profit Growth | -34.63% | 34.1% |
Profitability & Leverage
| Metric | TATVA | VALIANTORG |
|---|---|---|
| ROE | 5.38% | 4.38% |
| ROCE | 4.93% | 4.84% |
| Net Margin | 8.31% | 4.5% |
| Operating Margin | 11.83% | 8.29% |
| Debt to Equity | 0.15x | 0.33x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | TATVA | VALIANTORG |
|---|---|---|
| Promoter Holding | 72.02% | 37.87%▼ 0.02 pp |
| FII Holding | 3.93%▲ 0.11 pp | 0.21%▼ 0.07 pp |
| DII Holding | 3.11%▲ 0.12 pp | 0% |
| Public Holding | 20.94%▼ 0.23 pp | 61.92%▲ 0.1 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: TATVA CHIN PHARM CHEM and VALIANTORG.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.